[Pharmacognostic studies on Sanguis lignum Dracaenae cochinchinensis].

Zhongguo Zhong Yao Za Zhi

Department of Chinese Pharmacy, Guangxi College of Traditional Chinese Medicine, Nanning.

Published: November 1994

The resin of Dracaena cochinchinensis has been used as the substitute for Chinese drug Xuejie (Sanguis Draconis) for 20 years in China. The pharmacological, toxicological and clinical studies have shown that the former is similar to the latter in effects, and can be used as a substitute for the latter. This paper deals with the resources, morphological and histological characters, chemical and physical analysis of Sanguis Lignum Dracaenae Cochinchinensis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sanguis lignum
8
lignum dracaenae
8
[pharmacognostic studies
4
studies sanguis
4
dracaenae cochinchinensis]
4
cochinchinensis] resin
4
resin dracaena
4
dracaena cochinchinensis
4
cochinchinensis substitute
4
substitute chinese
4

Similar Publications

Clinical efficacy and mechanism of Qishen Yiqi Dripping Pills(QSYQ) have been well researched, but the compatibility mechanism underlying its therapeutic effect still requires further analysis. This study aims to explore the compatibility mechanism of QSYQ in treating myocardial ischemia. UPLC-Q-Exactive Orbitrap-MS technique was used to obtain the absorbed blood components of QSYQ.

View Article and Find Full Text PDF

Objective: To elucidate the chemical profile of Xanthocerais lignum's extracts of different polarities and their impact on rheumatoid arthritis (RA), we identified anti-RA markers and predicted their action mechanisms.

Methods: A collagen-induced arthritis rat model was established, and UPLC-Q-Exactive Orbitrap MS technology was employed to analyze and identify the chemical constituents within the alcohol extract of Xanthocerais lignum and its various extraction fractions, as well as their translocation into the bloodstream. Serum spectrum-effect correlation analysis was utilized to elucidate the pharmacodynamic material basis of Xanthocerais lignum against RA and to screen for Q-Markers.

View Article and Find Full Text PDF

Dalbergia cochinchinensis(DC) is chemically similar to the valuable and scarce Chinese herb Dalbergiae Odoriferae Lignum, and both of them belong to the Dalbergia Leguminosae. DC is used for treating cardiovascular diseases and cancer. However, its potent active ingredient groups and molecular mechanisms in anti-myocardial ischemia are not fully clarified.

View Article and Find Full Text PDF

Guan Xin Dan Shen formulation (GXDSF) is a widely used treatment for the management of coronary heart disease in China and is composed of three primary components: , Radix et Rhizoma and Radix et Rhizoma. However, the potential use of GXDSF for the management of diabetic cardiomyopathy (DCM) has not been previously assessed. The present study aimed to assess the effects of GXDSF on DCM, as well as the underlying mechanism.

View Article and Find Full Text PDF

UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples.

Curr Drug Metab

January 2022

The Second Clinical Medical College, and Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Diseases, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China.

Background: Caesalpinia sappan L. is a traditional medicinal plant that is used to promote blood circulation and treat stroke in China. Protosappanin B (PTB) is a unique homoisoflavone compound isolated from Sappan Lignum (the heartwood of Caesalpinia sappan L).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!